Ameet Mallik Adc Therapeutics Sa (ADCT) insider trading activity

ADCT Quotes by TradingView

Ameet Mallik is Chief Executive Officer of ADC Therapeutics SA. Currently has a direct ownership of 1.58 Million shares of ADCT, which is worth approximately $2.49 Million. The most recent transaction as insider was on Feb 13, 2025, when has been sold 650,000 shares (Common Shares) at a price of $1.61 per share, resulting in proceeds of $1,046,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.58M
35.26% 3M change
n/a 12M change
Total Value Held $2.49 Million

AMEET MALLIK Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 13 2025
BUY
Grant, award, or other acquisition
$1,046,500 $1.61 p/Share
650,000 Added 29.16%
1,579,005 Common Shares
Dec 06 2024
SELL
Payment of exercise price or tax liability
$746,013 $3.13 p/Share
238,343 Reduced 20.42%
929,005 Common Shares
May 07 2024
SELL
Open market or private sale
$133,194 $4.48 p/Share
29,731 Reduced 2.48%
1,167,348 Common Shares

Also insider at

RFL
Rafael Holdings, Inc. Real Estate
Director
ATRA
Atara Biotherapeutics, Inc. Healthcare
AM

Ameet Mallik

Chief Executive Officer
South San Francisco, CA

Track Institutional and Insider Activities on ADCT

Follow ADC Therapeutics SA and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADCT shares.

Notify only if

Insider Trading

Get notified when an Adc Therapeutics Sa insider buys or sells ADCT shares.

Notify only if

News

Receive news related to ADC Therapeutics SA

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ADCT